Surrogate markers of cardiovascular risk and chronic obstructive pulmonary disease: a large case-controlled study

M Fisk, CM McEniery, N Gale, K Mäki-Petäjä… - …, 2018 - Am Heart Assoc
Cardiovascular disease is a common comorbidity and cause of mortality in chronic
obstructive pulmonary disease. A better understanding of mechanisms of cardiovascular risk …

Short physical performance battery as a practical tool to assess mortality risk in chronic obstructive pulmonary disease

JM Fermont, D Mohan, M Fisk, CE Bolton… - Age and …, 2021 - academic.oup.com
Rationale chronic obstructive pulmonary disease (COPD) is a leading cause of mortality and
common in older adults. The BODE Index is the most recognised mortality risk score in …

Effects of resveratrol and genistein on nuclear factor‑κB, tumor necrosis factor‑α and matrix metalloproteinase‑9 in patients with chronic obstructive pulmonary disease

XJ Liu, HR Bao, XL Zeng… - Molecular medicine …, 2016 - spandidos-publications.com
Chronic airway inflammation and airway remodeling are the major pathophysiological
characteristics of chronic obstructive pulmonary disease (COPD). Resveratrol and genistein …

Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study

JM Fermont, CE Bolton, M Fisk, D Mohan, W Macnee… - PloS one, 2020 - journals.plos.org
In chronic obstructive pulmonary disease (COPD), acute exacerbation of COPD requiring
hospital admission is associated with mortality and healthcare costs. The ERICA study …

Short physical performance battery: what does each Sub-Test measure in patients with chronic obstructive pulmonary disease?

D Mohan, VS Benson, M Allinder… - … : Journal of the …, 2019 - pmc.ncbi.nlm.nih.gov
Objective: To identify phenotypic factors associated with the Short Physical Performance
Battery (SPPB) and its individual sub-tests: standing balance, 4‑meter gait speed (4mGS) …

Cardiovascular risk prediction using physical performance measures in COPD: results from a multicentre observational study

JM Fermont, M Fisk, CE Bolton, W MacNee… - BMJ open, 2020 - bmjopen.bmj.com
Objectives Although cardiovascular disease (CVD) is a common comorbidity associated with
chronic obstructive pulmonary disease (COPD), it is unknown how to improve prediction of …

Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA

H Pavey, MI Polkey, CE Bolton… - BMJ Open …, 2023 - bmjopenrespres.bmj.com
The relationship of circulating testosterone levels with health outcomes in people with
chronic obstructive pulmonary disease (COPD) is unknown. Aim To determine whether …

Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study

D Mohan, JR Forman, M Allinder, CM McEniery… - Thorax, 2018 - thorax.bmj.com
Cardiovascular and skeletal muscle manifestations constitute important comorbidities in
COPD, with systemic inflammation proposed as a common mechanistic link. Fibrinogen has …

Longitudinal follow-up of quadriceps strength and function in a COPD cohort after 3 years

SC Buttery, D Mohan, M Fisk… - European …, 2017 - Eur Respiratory Soc
Longitudinal follow-up of quadriceps strength and function in a COPD cohort after 3 years |
European Respiratory Society Skip to main content Main menu Home Current issue ERJ Early …

Using laser capture microdissection to study fiber specific signaling in locomotor muscle in COPD: a pilot study

D Mohan, A Lewis, MS Patel, KJ Curtis, JY Lee… - Muscle & …, 2017 - Wiley Online Library
Introduction Quadriceps dysfunction is important in chronic obstructive pulmonary disease
(COPD), with an associated increased proportion of type II fibers. Investigation of protein …